Advertisement

Nitric Oxide in Sepsis and Nitric Oxide in Sepsis and ARDS

  • H. Zhang
  • T. E. Stewart
  • J.-L. Vincent
Conference paper

Abstract

Septic shock, a major clinical problem with mortality rates of up to 70%, is characterized by systemic hypotension, impaired tissue O2 extraction capabilities and myocardial depression. Much interest has been focused on the role of nitric oxide (NO) in septic shock during the last decade. Following the discovery of the NO radical it was clear that NO could play a role in the vascular relaxation and hypotension during sepsis and endotoxaemia. In vitro studies showed that isolated macrophages produced increased amounts of nitrate and nitrite upon stimulation with lipopolysaccharides [1, 2]. This increase was shown to be caused by the increased production of NO, which was dependent on the presence of L-arginine and could be inhibited by analogs of L-arginine. The NO synthase enzyme responsible for production of NO in macrophages is inducible (iNOS) and differs from the constitutive NO synthase (cNOS) in endothelial cells. The cNOS is calcium and calmodulin dependent and releases small amounts of NO, whereas the iNOS is calcium and calmodulin independent and releases large amounts of NO for a prolonged period of time. The iNOS enzyme shown in macrophages can also be found in neutrophils, hepatocytes, myocardial cells and vascular smooth muscle cells stimulated with endotoxin or cytokines [3, 4, 5]. iNOS is expressed under the influence of endotoxin and several cytokines like tumor necrosis factor-α (TNF-α), interleukin-lβ (IL-Iβ) and interferon-γ [4, 6]. In general, one can say that cNOS plays a physiological role in maintaining organ perfusion, whereas iNOS plays a more pathological role (as in sepsis and endotoxaemia) leading to the production of excessive amounts of NO resulting in vascular relaxation and tissue damage [7].

Keywords

Nitric Oxide Nitric Oxide Septic Shock Methylene Blue Nitric Oxide Synthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Marietta MA, Yoon PS, Iyengar R et al (1988) Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 27:8706–8711CrossRefGoogle Scholar
  2. 2.
    Stuehr DJ, Gross SS, Sakuma I et al (1989) Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med 169:1011–1020PubMedCrossRefGoogle Scholar
  3. 3.
    Brady AJ, Poole-Wilson PA, Harding SE, Warren JB (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263:H1963–H1966PubMedGoogle Scholar
  4. 4.
    Geller DA, Nussler AK, Di Silvio M et al (1993) Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 90:522–526PubMedCrossRefGoogle Scholar
  5. 5.
    Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142PubMedGoogle Scholar
  6. 6.
    Kilbourn RG, Jubran A, Gross SS et al (1990) NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87:3629–3632PubMedCrossRefGoogle Scholar
  7. 7.
    Wright CE, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48–57PubMedCrossRefGoogle Scholar
  8. 8.
    Evans T, Carpenter A, Kinderman H, Cohen J (1993) Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77–81PubMedGoogle Scholar
  9. 9.
    Salvemini D, Korbut R, Anggard E, Vane JR (1990) Immediate release of nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 87:2593–2697PubMedCrossRefGoogle Scholar
  10. 10.
    Nakae H, Endo S, Inada K et al (1996) Nitrite/nitrate (Nox) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 92:131–139PubMedGoogle Scholar
  11. 11.
    Endo S, Inada K, Nakae H et al (1996) Nitrite/nitrate (Nox) and cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 91:347–356PubMedGoogle Scholar
  12. 12.
    Gomez-Jimenez J, Salgado A, Mourelle M et al (1995) L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253–258PubMedCrossRefGoogle Scholar
  13. 13.
    Wong HR, Carcillo JA, Burekart G, Kaplan SS (1996) Nitric oxide production in critically ill patients. Arch Dis Child 74:482–489PubMedCrossRefGoogle Scholar
  14. 14.
    Mitaka C, Hirata Y, Ichikawa K et al (1995) Effects of nitric oxide synthase inhibitor on hemodynamic change and 02 delivery in septic dogs. Am J Physiol 268:H2017–H2023PubMedGoogle Scholar
  15. 15.
    Lorente J, Landin L, De Pablo R et al (1993) L-arginine pathway in sepsis. Crit Care Med 21: 1287–1295PubMedCrossRefGoogle Scholar
  16. 16.
    Finkel MS, Oddis CV, Jacob TD et al (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387–389PubMedCrossRefGoogle Scholar
  17. 17.
    Decking UKM, Flesche CW, Gödecke A, Schrader J (1995) Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol 268:H2460–H2465PubMedGoogle Scholar
  18. 18.
    Klabunde RE, Coston AF (1995) Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock 3:73–78PubMedGoogle Scholar
  19. 19.
    Vincent J-L, Colice G, Grover R (1995) The effects of 546C88 on left ventricular performance in patients with septic shock. Intensive Care Med 21:S20 (abstract)Google Scholar
  20. 20.
    Meng X, Ao L, Brown JM et al (1997) Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 7:111–118PubMedCrossRefGoogle Scholar
  21. 21.
    Keller RS, Jones JJ, Kim KF (1995) Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide? Shock 4:338–344PubMedCrossRefGoogle Scholar
  22. 22.
    Avontuur JAM, Ince BC (1995) Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 76:418–425PubMedCrossRefGoogle Scholar
  23. 23.
    Cohen RI, Shapir Y, Chen L, Scharf SM (1998) Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia. Crit Care Med 26:738–747PubMedCrossRefGoogle Scholar
  24. 24.
    Spath Jr JA, Sloane PJ, Gee MH, Albertine KH (1994) Loss of endothelium-dependent vasodilation in the pulmonary vessels of sheep after prolonged endotoxin. J Appl Physiol 76: 361–369PubMedGoogle Scholar
  25. 25.
    Mulder MF, Van Lambalgen AA, Huisman E et al (1994) Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 266:H1558–H1564PubMedGoogle Scholar
  26. 26.
    Robertson FM, Offner PJ, Ciceri DP (1994) Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129:149–156PubMedCrossRefGoogle Scholar
  27. 27.
    Zhang H, Rogiers P, Smail N et al (1997) Effects of nitric oxide on regional blood flow and oxygen extraction capabilities in endotoxic shock. J Appl Physiol 83:1164–1173PubMedGoogle Scholar
  28. 28.
    Henderson JL, Statman R, Cunnigham JN et al (1994) The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia. Arch Surg 129:1271–1275PubMedCrossRefGoogle Scholar
  29. 29.
    Ayuse T, Brienza N, Revelly JP (1995) Role of nitric oxide in porcine live circulation under normal and endotoxemic conditions. J Appl Physiol 78:1319–1329PubMedGoogle Scholar
  30. 30.
    Pastor CM, Pay en DM (1994) Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 2:196–202PubMedCrossRefGoogle Scholar
  31. 31.
    Nishida J, McCuskey RS, McDonnell D, Fox ES (1994) Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 267:G1135–G1141PubMedGoogle Scholar
  32. 32.
    Wang Y, Mathews WR, Guido DM et al (1995) Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 4:282–288PubMedCrossRefGoogle Scholar
  33. 33.
    Spain DA, Wilson MA, Bar-Natan MF, Garrison RN (1994) Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 36:720–725PubMedCrossRefGoogle Scholar
  34. 34.
    Walker TA, Curtis SE, King-Van Vlack CE et al (1995) Effects of nitric oxide synthase inhibition on regional hemodynamics and oxygen transport in endotoxic dogs. Shock 4:415–420PubMedGoogle Scholar
  35. 35.
    Werner J, Rivera J, Castillo CF (1997) Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery 121:23–30PubMedCrossRefGoogle Scholar
  36. 36.
    Spain DA, Wilson MA, Bloom ITM, Garrison RN (1994) Renal microvascular responses to sepsis are dependent on nitric oxide. J Surg Res 56:524–529PubMedCrossRefGoogle Scholar
  37. 37.
    Kubes P, Granger DN (1992) Nitric oxide modulates microvascular permeability. Am J Physiol 262:H611–H615PubMedGoogle Scholar
  38. 38.
    Kurose I, Kubes P, Wolf R (1993) Inhibition on nitric oxide production: mechanisms of vascular albumin leakage. Circ Res 73:164–171PubMedCrossRefGoogle Scholar
  39. 39.
    Oliver JA (1992) Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 151:506–511PubMedCrossRefGoogle Scholar
  40. 40.
    Kubes P (1993) Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 264:G143–G149PubMedGoogle Scholar
  41. 41.
    Payne D, Kubes P (1993) Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 265:G189–G195PubMedGoogle Scholar
  42. 42.
    Rumbaut RE, McKay MK, Huxley VH (1995) Capillary hydraulic conductivity is decreased by nitric oxide synthase inhibition. Am J Physiol 368:H1856–H1861Google Scholar
  43. 43.
    Statman R, Cheng W, Cunningham JN et al (1994) Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res 57:93–98PubMedCrossRefGoogle Scholar
  44. 44.
    Kurose I, Wolf R, Grisham MB, Granger DN (1995) Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am J Physiol 268:H2224–H2231PubMedGoogle Scholar
  45. 45.
    Fukatsu K, Saito H, Fukushima R et al (1995) Detrimental effects of nitric oxide synthase inhibitor (N-co-nitro-L-arginine-methyl-ester) in a murine sepsis model. Arch Surg 130:410–414PubMedCrossRefGoogle Scholar
  46. 46.
    Cobb JP, Natanson C, Quezado ZMN et al (1995) Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 268:H1634–H1642PubMedGoogle Scholar
  47. 47.
    Minnard EA, Shou J, Naama H et al (1994) Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129:142–148PubMedCrossRefGoogle Scholar
  48. 48.
    Laniyonu AA, Coston AF, Klabunde RE (1997) Endotoxin-induced microvascular leakage is prevented by a PAF antagonist and NO synthase inhibitor. Shock 7:49–54PubMedCrossRefGoogle Scholar
  49. 49.
    Fukatsu K, Saito H, Fukushima R et al (1996) Effects of three inhibitors of nitric oxide synthase on host resistance to bacterial infection. Inflamm Res 45:109–112PubMedCrossRefGoogle Scholar
  50. 50.
    Szabö C, Mitchell JA, Thiemermann C, Vane JR (1993) Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 108:786–792PubMedCrossRefGoogle Scholar
  51. 51.
    Mitchell JA, Kohlhaas KL, Sorrentino R et al (1993) Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasconstrictors. Br J Pharmacol 109:265–270PubMedCrossRefGoogle Scholar
  52. 52.
    Morris S, Billiar T (1994) New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:E829–E839PubMedGoogle Scholar
  53. 53.
    Salter M, Knowles RG, Moncada S (1991) Widespread tissue distribution, species distribution and changes in activity of Ca2+-dependent and Ca2+-independent nitric oxide synthase. FEBS 291:145–149CrossRefGoogle Scholar
  54. 54.
    Wallis G, Brackett D, Lerner M et al (1996) In vivo spin trapping of nitric oxide generated in the small intestine, liver, and kidney during the development of endotoxemia: a time-course study. Shock 6:274–278PubMedCrossRefGoogle Scholar
  55. 55.
    Cobb JP, Natanson C, Hoffman WD et al (1992) Nω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176:1175–1182PubMedCrossRefGoogle Scholar
  56. 56.
    Parker JL, Adams HR (1993) Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 72:539–551PubMedCrossRefGoogle Scholar
  57. 57.
    Wang P, Ba ZF, Chaudry IH (1995) Endothelium-dependent relaxation is depressed at the macro-and microcirculatory levels during sepsis. Am J Physiol 269:R988–R994PubMedGoogle Scholar
  58. 58.
    Lu J-L, Schmiege III LM, Kuo L, Liao JC (1996) Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun 225:1–5PubMedCrossRefGoogle Scholar
  59. 59.
    Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME (1993) Tumor necrosis factor downregu-lates an endothelial nitric oxide synthase mRNA by shortening its half life. Circ Res 73: 205–209PubMedCrossRefGoogle Scholar
  60. 60.
    Laszlo F, Whittle BJR, Evans SM, Moncada S (1995) Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol 283:47–53PubMedCrossRefGoogle Scholar
  61. 61.
    Gardiner SM, Kemp PA, Bennett MT (1995) Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotox-aemic rats. Br J Pharmacol 116:2005–2016PubMedCrossRefGoogle Scholar
  62. 62.
    Nava E, Palmer RMJ, Moncada S (1991) Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338:1555–1557PubMedCrossRefGoogle Scholar
  63. 63.
    Radomski MW, Palmer RM, Moncada S (1990) Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87:10043–10047PubMedCrossRefGoogle Scholar
  64. 64.
    DiRosa M, Radomski M, Carnuccio R et al (1990) Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 172:1246–1252CrossRefGoogle Scholar
  65. 65.
    McCall TB, Palmer RM, Moncada S (1991) Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol 21:2523–2527PubMedCrossRefGoogle Scholar
  66. 66.
    Pittner R, Spitzer J (1992) Endotoxin and TNF-α directly stimulate nitric oxide formation in cultured rat hepatocytes from chronically endotoxemic rats. Biochem Biophys Res Commun 185:430–435PubMedCrossRefGoogle Scholar
  67. 67.
    Rees DD, Cellek S, Palmer RM et al (1990) Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 173:541–547PubMedCrossRefGoogle Scholar
  68. 68.
    Knowles RG, Salter M, Brooks SL et al (1990) Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 172:1042–1048PubMedCrossRefGoogle Scholar
  69. 69.
    Paya D, Gray G, Fleming I et al (1993) Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats. Circ Shock 41: 103–112PubMedGoogle Scholar
  70. 70.
    Misko TP, Moore WM, Kasten TP et al (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119–125PubMedCrossRefGoogle Scholar
  71. 71.
    Szabo C, Southan G, Thiemermann C (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472–12476PubMedCrossRefGoogle Scholar
  72. 72.
    Chamulitrat W, Skrepnik NV, Spitzer JJ (1996) Endotoxin-induced oxidative stress in the rat small intestine: role of nitric oxide. Shock 5:217–222PubMedCrossRefGoogle Scholar
  73. 73.
    Aranow JS, Zhuang J, Wang H et al (1996) A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock 5:116–121PubMedCrossRefGoogle Scholar
  74. 74.
    Southan GJ, Zingarelli B, O’Connor M et al (1996) Spontaneous rearrangement of amino-alkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol 117:619–632PubMedCrossRefGoogle Scholar
  75. 75.
    Vromen A, Arkovitz MS, Zingarelli B et al (1996) Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat. Shock 6:248–253PubMedCrossRefGoogle Scholar
  76. 76.
    Ochoa J, Curti B, Peitzman A (1992) Increased circulating nitrogen oxides after human tumor immunotherapy correlate with toxic hemodynamic changes. J Natl Cancer Inst 84:864–867PubMedCrossRefGoogle Scholar
  77. 77.
    Wong H, Carcillo J, Burkart G et al (1995) Increased serum nitrate and nitrite concentrations in children with sepsis syndrome. Crit Care Med 23:835–842PubMedCrossRefGoogle Scholar
  78. 78.
    Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557–1558PubMedCrossRefGoogle Scholar
  79. 79.
    Kiehl MG, Ostermann H, Meyer J, Kienast J (1997) Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive Care Med 23:561–566PubMedCrossRefGoogle Scholar
  80. 80.
    Neilly IJ, Copland M, Haj M et al (1995) Plasma nitrate concentrations in neutropenic and non-neutropenic patients with suspected septicaemia. Br J Haematol 89:199–202PubMedCrossRefGoogle Scholar
  81. 81.
    Avontuur JA, Nolthenius RPT, van Bodegom JW, Bruining JA (1998) Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study. Crit Care Med 26:660–667PubMedCrossRefGoogle Scholar
  82. 82.
    Hibbs J, Westenfelder C, Taintor R (1992) Evidence for cytokine-induced nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867–877PubMedCrossRefGoogle Scholar
  83. 83.
    Zaccardelli D, Grover R, Colice G (1995) Hemodynamic effects of 546C88 (L-NG-methy-larginine HCL) in an open label, dose escalation study of patients with septic shock. Intensive Care Med 21:S21 (abstract)Google Scholar
  84. 84.
    Schneider F, Lutun P, Hasselmann M et al (1992) Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18:309–311PubMedCrossRefGoogle Scholar
  85. 85.
    Preiser J-C, Lejeune P, Roman A et al (1995) Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23:259–264PubMedCrossRefGoogle Scholar
  86. 86.
    Daemen-Gubbels CR, Groeneveld PH, Groeneveld AM et al (1995) Methylene blue increases myocardial function in septic shock. Crit Care Med 23:1363–1370PubMedCrossRefGoogle Scholar
  87. 87.
    Zhang H, Rogiers P, Spapen H et al (1996) Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock. Arch Surg 131:767–774PubMedCrossRefGoogle Scholar
  88. 88.
    Greenberg S, Xie J, Wang Y et al (1993) Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation. J Appl Physiol 74:2394–2403PubMedGoogle Scholar
  89. 89.
    Myers PR, Wright TF, Tanner MA, Adams HR (1992) EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin. Am J Physiol 262:H710–H718Google Scholar
  90. 90.
    Siegfride MR, Erhardt J, Rider T et al (1992) Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 260:668–675Google Scholar
  91. 91.
    Pabla R, Buda AJ, Flynn DM et al (1995) Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol 269:H1113–H1121PubMedGoogle Scholar
  92. 92.
    Schlüter KD, Weber M, Schraveb E, Piper HM (1994) NO donor SIN-1 protects against re-oxygenation-induced cardiomyocyte injury by a dual action. Am J Physiol 267:H1461–H1466PubMedGoogle Scholar
  93. 93.
    Pastor CM, Losser MR, Payen D (1995) Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 22:1547–1553PubMedGoogle Scholar
  94. 94.
    Frederick JA, Hasseigren PO, Davis S et al (1993) Nitric oxide may upregulate in vivo hepatic protein synthesis during endotoxemia. Arch Surg 128:152–157PubMedCrossRefGoogle Scholar
  95. 95.
    Boughton-Smith NK, Hucheson IR, Deakin AM (1994) Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 191:485–488CrossRefGoogle Scholar
  96. 96.
    Andrews FJ, Malcontenti-Wilson C, O’Brien PE (1994) Protection against gastric ischemia-reperfusion injury by nitric oxide generators. Dig Dis Sci 39:366–373PubMedCrossRefGoogle Scholar
  97. 97.
    Carey C, Siegfried MR, Ma X-L et al (1992) Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Cire Shock 38:209–216Google Scholar
  98. 98.
    Kurose I, Wolf R, Grisham MB, Granger DN (1994) Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 74:376–382PubMedCrossRefGoogle Scholar
  99. 99.
    Gauthier TW, Davenpeck KL, Lefer AM (1994) Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 267:G562–G568PubMedGoogle Scholar
  100. 100.
    Bubanyi GM, Ho EH, Cantor EH et al (1991) Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 181:1392–1397CrossRefGoogle Scholar
  101. 101.
    Gryglewski RJ, Palmer RMJ, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454–456PubMedCrossRefGoogle Scholar
  102. 102.
    Moilanen E, Vuorinen P, Kankaanranta H et al (1993) Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 109:852–858PubMedCrossRefGoogle Scholar
  103. 103.
    Kumins NH, Hunt J, Gamelli RL, Filkins JP (1997) Molsidomine increases endotoxic survival and decreases cytokine production. Shock 7:200–205PubMedCrossRefGoogle Scholar
  104. 104.
    Christopher TA, Ma X-L, Lefer AM (1994) Beneficial actions of S-nitroso-N-acetylpenicil-lamine, a nitric oxide donor, in murine traumatic shock. Shock 1:19–24PubMedCrossRefGoogle Scholar
  105. 105.
    Dellinger RP, Zimmerman JL, Taylor RW et al (1998) Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Crit Care Med 26:15–23PubMedCrossRefGoogle Scholar
  106. 106.
    Rossaint R, Falke KJ, Lopez F (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399–405PubMedCrossRefGoogle Scholar
  107. 107.
    Gerlach H, Rossaint R, Pappert D (1993) Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23:499–502PubMedCrossRefGoogle Scholar
  108. 108.
    Gottlieb SS, Wood LD, Hansen DE (1987) The effect of nitroprusside on pulmonary edema, oxygen exchange, and blood flow in hydrochloric aid aspiration. Anesthesiology 67: 203–210PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • H. Zhang
    • 1
  • T. E. Stewart
    • 1
  • J.-L. Vincent
    • 2
  1. 1.Division of Respiratory Medicine, Mount Sinai HospitalToronto UniversityTorontoCanada
  2. 2.Dept. of Intensive Care, Erasme University HospitalFree University of BrusselsBrusselsBelgium

Personalised recommendations